Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Adding Dexmedetomidine as an Adjuvant to The Local Anesthetic in QL3 in Patient Undergoing Caesarean Section

NCT07072650 is registered in ClinicalTrials.gov with Majid Fakhir Mutar Alhamaaidah as lead sponsor.

NCT NCT07072650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Adding Dexmedetomidine as an Adjuvant to The Local Anesthetic in QL3 in Patient Undergoing Caesarean Section
Lead sponsor
Majid Fakhir Mutar Alhamaaidah
Phase
Phase 1
Overall status
Completed
Start date
January 25, 2025
Completion date
June 25, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caesarean section, dexmedetomidine, postoperative analgesia, quadratus lumborum block